Join the Idiopathic (Immune) Thrombocytopenic Purpura group to help and get support from people like you.
Idiopathic (Immune) Thrombocytopenic Purpura News
Related terms: Immune Thrombocytopenic Purpura, ITP
Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
DURHAM, N.C., June 27, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases wh...
FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
SOUTH SAN FRANCISCO, Calif., April 17, 2018 /PRNewswire/ – Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved Tavalisse (fostamatinib...
FDA Extends Use of Promacta (eltrombopag) in Pediatric Patients with Immune Thrombocytopenic Purpura
August 24, 2015 – The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood dis...
FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
SAN DIEGO, June 12, 2015 --(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the FDA has approved a supplemental New Drug Application (sNDA) for the use of Promacta...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, triamcinolone, cortisone, dexamethasone, rituximab